久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/11/18 | 4,210 | 4,228 | 4,188 | 4,224 | +4 | +0.1% | 77,600 |
2024/11/15 | 4,284 | 4,284 | 4,215 | 4,220 | -19 | -0.4% | 74,800 |
2024/11/14 | 4,283 | 4,288 | 4,239 | 4,239 | -56 | -1.3% | 83,500 |
2024/11/13 | 4,350 | 4,357 | 4,284 | 4,295 | -73 | -1.7% | 97,600 |
2024/11/12 | 4,399 | 4,399 | 4,321 | 4,368 | -7 | -0.2% | 110,500 |
2024/11/11 | 4,388 | 4,428 | 4,351 | 4,375 | +2 | ±0% | 145,000 |
2024/11/08 | 4,450 | 4,464 | 4,347 | 4,373 | -87 | -2% | 141,800 |
2024/11/07 | 4,440 | 4,483 | 4,437 | 4,460 | +22 | +0.5% | 98,700 |
2024/11/06 | 4,475 | 4,496 | 4,418 | 4,438 | -37 | -0.8% | 136,600 |
2024/11/05 | 4,464 | 4,507 | 4,444 | 4,475 | -5 | -0.1% | 178,500 |
2024/11/01 | 4,418 | 4,525 | 4,390 | 4,480 | -8 | -0.2% | 164,100 |
2024/10/31 | 4,430 | 4,500 | 4,430 | 4,488 | +84 | +1.9% | 238,700 |
2024/10/30 | 4,393 | 4,433 | 4,388 | 4,404 | +39 | +0.9% | 183,000 |
2024/10/29 | 4,338 | 4,399 | 4,311 | 4,365 | +27 | +0.6% | 141,500 |
2024/10/28 | 4,311 | 4,354 | 4,277 | 4,338 | +55 | +1.3% | 154,700 |
2024/10/25 | 4,287 | 4,299 | 4,252 | 4,283 | -16 | -0.4% | 141,100 |
2024/10/24 | 4,323 | 4,359 | 4,290 | 4,299 | -47 | -1.1% | 184,100 |
2024/10/23 | 4,334 | 4,385 | 4,300 | 4,346 | +43 | +1% | 203,600 |
2024/10/22 | 4,300 | 4,333 | 4,293 | 4,303 | +4 | +0.1% | 158,300 |
2024/10/21 | 4,280 | 4,306 | 4,240 | 4,299 | +8 | +0.2% | 153,400 |
2024/10/18 | 4,320 | 4,364 | 4,251 | 4,291 | +4 | +0.1% | 236,400 |
2024/10/17 | 4,076 | 4,298 | 4,076 | 4,287 | +211 | +5.2% | 315,900 |
2024/10/16 | 4,050 | 4,154 | 4,050 | 4,076 | -7 | -0.2% | 128,500 |
2024/10/15 | 4,080 | 4,139 | 4,033 | 4,083 | +45 | +1.1% | 143,900 |
2024/10/11 | 4,095 | 4,198 | 4,025 | 4,038 | -12 | -0.3% | 334,800 |
2024/10/10 | 4,005 | 4,062 | 3,982 | 4,050 | +24 | +0.6% | 94,700 |
2024/10/09 | 4,045 | 4,098 | 4,007 | 4,026 | +1 | ±0% | 126,500 |
2024/10/08 | 3,960 | 4,026 | 3,957 | 4,025 | +24 | +0.6% | 121,300 |
2024/10/07 | 4,020 | 4,031 | 3,985 | 4,001 | -6 | -0.1% | 127,300 |
2024/10/04 | 3,947 | 4,027 | 3,938 | 4,007 | +57 | +1.4% | 127,400 |
2024/10/03 | 3,954 | 3,966 | 3,928 | 3,950 | +50 | +1.3% | 126,800 |
2024/10/02 | 3,865 | 3,910 | 3,864 | 3,900 | +13 | +0.3% | 119,900 |
2024/10/01 | 3,863 | 3,898 | 3,852 | 3,887 | +24 | +0.6% | 74,200 |
2024/09/30 | 3,871 | 3,897 | 3,851 | 3,863 | -97 | -2.4% | 89,900 |
2024/09/27 | 3,991 | 4,015 | 3,958 | 3,960 | -51 | -1.3% | 79,800 |
2024/09/26 | 3,935 | 4,011 | 3,929 | 4,011 | +82 | +2.1% | 136,500 |
2024/09/25 | 3,903 | 3,956 | 3,892 | 3,929 | +26 | +0.7% | 76,100 |
2024/09/24 | 3,928 | 3,928 | 3,893 | 3,903 | -25 | -0.6% | 92,700 |
2024/09/20 | 3,955 | 3,992 | 3,916 | 3,928 | -20 | -0.5% | 208,600 |
2024/09/19 | 3,946 | 3,984 | 3,909 | 3,948 | +38 | +1% | 74,400 |
2024/09/18 | 3,940 | 3,961 | 3,874 | 3,910 | -29 | -0.7% | 102,800 |
2024/09/17 | 3,945 | 3,980 | 3,886 | 3,939 | +14 | +0.4% | 133,300 |
2024/09/13 | 3,937 | 3,948 | 3,897 | 3,925 | -44 | -1.1% | 93,000 |
2024/09/12 | 3,965 | 4,011 | 3,934 | 3,969 | +14 | +0.4% | 99,600 |
2024/09/11 | 4,035 | 4,035 | 3,923 | 3,955 | -85 | -2.1% | 71,300 |
2024/09/10 | 4,020 | 4,066 | 4,011 | 4,040 | +3 | +0.1% | 127,400 |
2024/09/09 | 3,988 | 4,040 | 3,972 | 4,037 | +43 | +1.1% | 82,300 |
2024/09/06 | 4,008 | 4,016 | 3,977 | 3,994 | +3 | +0.1% | 62,200 |
2024/09/05 | 4,006 | 4,029 | 3,974 | 3,991 | -15 | -0.4% | 92,400 |
2024/09/04 | 3,999 | 4,060 | 3,985 | 4,006 | -60 | -1.5% | 92,600 |
151~
200
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 402,100円 | +5.8% | +1.2% | 2.98% | 13.34倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 204,700円 | +8.4% | +0.2% | 2.05% | 14.87倍 | 1.78倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 93,200円 | -11.0% | +206.6% | 0.00% | 9.26倍 | 2.28倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 346,500円 | +3.8% | -19.9% | 3.92% | 11.25倍 | 0.86倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 314,100円 | +8.0% | -15.3% | 3.95% | 8.82倍 | 0.86倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム